INS and fatty liver disease: In murine models, fecal microbiota transplant from mice with metabolic syndrome can induce metabolic syndrome and fatty liver disease in previously healthy mice [29], and human studies have shown that insulin function (which is strongly associated with MASLD) improved in participants who were obese after receiving a fecal microbiota transplant from donors who were lean [30].